default author photo

Chel Hun Choi

Sungkyunkwan University - Samsung Medical Center

81, Irwon- Ro

Gangnam-gu

Seoul, 135-710

Korea, Republic of (South Korea)

SCHOLARLY PAPERS

3

DOWNLOADS

131

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Efficacy and Safety of Triplet Maintenance Therapy (Olaparib, Pembrolizumab, And Bevacizumab) in BRCA Non-Mutated Patients with Platinum-Sensitive Recurrent Ovarian Cancer: A Multi-Centre, Single-Arm Phase II Study (OPEB-01/APGOT-OV4/MK 3475-B32)

Number of pages: 28 Posted: 21 Oct 2022
Yonsei University - Department of Obstetrics and Gynecology, Sungkyunkwan University - Biomedical Statistics Center, Seoul National University - Department of Obstetrics and Gynecology, Sungkyunkwan University - Department of Obstetrics and Gynecology, Yonsei University - Department of Obstetrics and Gynecology, Seoul National University - Department of Obstetrics and Gynecology, Sungkyunkwan University - Samsung Medical Center, Chinese Academy of Medical Sciences - Center for Gynecologic CancerNational Cancer Center, Korea - Center for Gynecologic Cancer, National University Health System (NUHS) - National University Cancer Institute, National University Health System (NUHS) - National University Cancer Institute and Yonsei University - Department of Obstetrics and Gynecology
Downloads 76 (830,555)

Abstract:

Loading...

Ovarian Neoplasms, Platinum-resistant, BRCA wild type, PARP inhibitor, Immunotherapy

2.

Efficacy and Safety of Pembrolizumab With or Without Lenvatinib in Recurrent Uterine Carcinosarcoma: a Real-World Single-Center Study

Number of pages: 25 Posted: 01 Oct 2025
Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University School of Medicine, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Department of Obstetrics and Gynecology and Sungkyunkwan University - Samsung Medical Center
Downloads 36 (1,236,159)

Abstract:

Loading...

Uterine carcinosarcoma, Recurrent endometrial cancer, Immunotherapy, Pembrolizumab, Real-world data

3.

Reassessing recurrence risk in fertility-sparing surgery for borderline ovarian tumors: cystectomy versus unilateral salpingo-oophorectomy using propensity score overlap weighting

Number of pages: 26 Posted: 20 Mar 2026
Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University School of Medicine, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center and Sungkyunkwan University - Samsung Medical Center
Downloads 19 (1,459,862)

Abstract:

Loading...

borderline ovarian tumor, fertility-sparing surgery, ovarian cystectomy, propensity score overlap weighting